to BioTechniques free email alert service to receive content updates.
Cell Biology
Cancer-related antibodies
Epitomics' novel cancer-related antibodies were developed through a partnership with the National Cancer Institute's Center for Cancer Research.
The goal of the partnership was to develop novel, high-quality reagents for
cancer research and make them available to the scientific community. The 23
antibodies already made under the collaboration are available for purchase
in the USA directly through Epitomics and around the world through Epitomics
international distributors. It is anticipated that another 20 antibodies
will be developed through this partnership and released by Epitomics over
the next 2 years.
This Product is made by:
